Active implantable medical devices. Electromagnetic compatibility. EMC test protocols for implantable cardiac pacemakers, implantable cardioverter defibrillators and cardiac resynchronization devices

2019 ◽  
2021 ◽  
Author(s):  
Ting-Wei Wang ◽  
Ting-Tse Lin

Electromagnetic compatibility (EMC) in biomedical applications is a significant issue related to the user’s life safety, especially in implantable medical devices. Cardiovascular diseases and neurodegenerative disorders are the main chronic disease worldwide that rely on implantable treatment devices such as cardiac pacemakers and vagus nerve stimulators. Both devices must have high EMC to avoid electromagnetic interference-induced health risks, even death during the treatment. Thus, it is important to understand how EMI can affect implantable devices and proactively protect devices from electromagnetic interference, providing reliable and safe implantable device therapy. To this end, this chapter comprehensively introduces the clinical issues and provides EMC requirements for the implantable device such as a cardiac pacemaker and vagus nerve stimulator. The significance of this chapter is to present the EMC important issues in medical engineering that can help to evolve reliable and secure implantable device development in the future.


2015 ◽  
Vol 26 (4) ◽  
pp. 356-363
Author(s):  
Melanie T. Gura

Since the introduction of implantable cardiac pacemakers in 1958 and implantable cardioverter-defibrillators in 1980, these devices have been proven to save and prolong lives. Pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy are deemed life-sustaining therapies. Despite these life-saving technologies, all patients ultimately will reach the end of their lives from either their heart disease or development of a terminal illness. Clinicians may be faced with patient and family requests to withdraw these life-sustaining therapies. The purpose of this article is to educate clinicians about the legal and ethical principles that underlie withdrawal of life-sustaining therapies such as device deactivation and to highlight the importance of proactive communication with patients and families in these situations.


Author(s):  
N. Sertac Artan ◽  
Reza K. Amineh

Implantable medical devices such as pacemakers, implantable cardioverter defibrillators, deep brain stimulators, retinal and cochlear implants are gaining significant attraction and growth due to their capability to monitor the health condition in real time, diagnose a particular disease, or provide treatment for a particular disease. In order to charge these devices, wireless power transfer technology is considered as a powerful means. This eliminates the need for extra surgery to replace the battery. In this chapter, some of the major implanted medical devices are reviewed. Then, various wireless power transfer configurations are reviewed briefly for charging such devices. The chapter continues with reviewing wireless power transfer configurations based on the multi-layer printed or non-printed planar spiral coils. At the end, some of the recent works related to using multi-layer planar spiral coils for safe and efficient powering of IMDs will be discussed.


Author(s):  
N. Sertac Artan ◽  
Reza K. Amineh

Implantable medical devices such as pacemakers, implantable cardioverter defibrillators, deep brain stimulators, retinal and cochlear implants are gaining significant attraction and growth due to their capability to monitor the health condition in real time, diagnose a particular disease, or provide treatment for a particular disease. In order to charge these devices, wireless power transfer technology is considered as a powerful means. This eliminates the need for extra surgery to replace the battery. In this chapter, some of the major implanted medical devices are reviewed. Then, various wireless power transfer configurations are reviewed briefly for charging such devices. The chapter continues with reviewing wireless power transfer configurations based on the multi-layer printed or non-printed planar spiral coils. At the end, some of the recent works related to using multi-layer planar spiral coils for safe and efficient powering of IMDs will be discussed.


Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Eloi Marijon ◽  
Rui Providencia ◽  
Pascal Defaye ◽  
Didier Klug ◽  
Daniel Gras ◽  
...  

Background: Data regarding sex specificities in the use, benefits and complications of implantable cardioverter-defibrillators (ICDs) in primary prevention in the real-world European setting are sparse. Methods: Using a large multicentric cohort of consecutive patients referred for ICD implantation for primary prevention (2002-2012), in the setting of coronary artery disease or dilated cardiomyopathy, we examined potential sex differences in subjects’ characteristics and outcomes. Results: Of 5,539 patients, only 837 (15.1%) were women and 53.8% received cardiac resynchronization therapy (CRT-D). Compared to men, women presented a significantly higher proportion of dilated cardiomyopathy (60.2% vs. 36.2%, P120ms: 74.6% vs. 68.5%, P=0.003), higher New York Heart Association functional class (2.5±0.7 vs. 2.4±0.7, P=0.003) and lower prevalence of atrial fibrillation (18.7% vs. 24.9%, P<0.001). During a 16,786 patient-years follow-up, overall, fewer appropriate therapies were observed in women (HR = 0.59, CI95% 0.45-0.76; P<0.001). By contrast, no sex-specific interaction was observed for inappropriate shocks (OR for women = 1.00, 95%CI 0.74-1.35, P=0.997) and mortality (HR = 0.87; 95%CI 0.66-1.15, P=0.324), with similar patterns of cause of deaths. Conclusion: In our real life registry, women account for the minority of ICD recipients. While female ICD recipients present with features of more severe heart failure in the setting of primary prevention of sudden cardiac death, we observed they have a 40% lower incidence of appropriate therapies.


Sign in / Sign up

Export Citation Format

Share Document